Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Mediators of Inflammation
|
December 13, 2017
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
Marcia L Moss, Dmitry Minond
Analytical Biochemistry
|
June 6, 2007
Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening
Marcia L Moss, Fred H Rasmussen
Biochemistry
|
June 9, 2004
Therapeutic benefits from targeting of ADAM family members
Marcia L Moss, Jörg W Bartsch
Essays in Biochemistry
|
December 5, 2002
Shedding of membrane proteins by ADAM family proteases
Marcia L Moss, Millard H Lambert
Nature Clinical Practice. Rheumatology
|
April 17, 2008
Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
Marcia L Moss, Liora Sklair-Tavron, Raphael Nudelman
Journal of Neurochemistry
|
October 15, 2013
EphrinA/EphA-induced ectodomain shedding of neural cell adhesion molecule regulates growth cone repulsion through ADAM10 metalloprotease
Leann H Brennaman, Marcia L Moss, Patricia F Maness
Current Pharmaceutical Biotechnology
|
February 22, 2008
ADAM10 as a target for anti-cancer therapy
Marcia L Moss, Alexander Stoeck, Wenbo Yan, et al.
Clinical Biochemistry
|
October 18, 2011
Potential of fluorescent metalloproteinase substrates for cancer detection
Roopali Roy, David Zurakowski, Susan Pories, et al.
Combinatorial Chemistry & High Throughput Screening
|
December 18, 2009
Fluorescent substrates useful as high-throughput screening tools for ADAM9
Marcia L Moss, Fred H Rasmussen, Raphael Nudelman, et al.
Analytical Biochemistry
|
September 18, 2016
Fluorescent substrates for ADAM15 useful for assaying and high throughput screening
Marcia L Moss, Miles A Miller, Nikola Vujanovic, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Mediators of Inflammation
|
December 13, 2017
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
Marcia L Moss, Dmitry Minond
Analytical Biochemistry
|
June 6, 2007
Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening
Marcia L Moss, Fred H Rasmussen
Biochemistry
|
June 9, 2004
Therapeutic benefits from targeting of ADAM family members
Marcia L Moss, Jörg W Bartsch
Essays in Biochemistry
|
December 5, 2002
Shedding of membrane proteins by ADAM family proteases
Marcia L Moss, Millard H Lambert
Nature Clinical Practice. Rheumatology
|
April 17, 2008
Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
Marcia L Moss, Liora Sklair-Tavron, Raphael Nudelman
Journal of Neurochemistry
|
October 15, 2013
EphrinA/EphA-induced ectodomain shedding of neural cell adhesion molecule regulates growth cone repulsion through ADAM10 metalloprotease
Leann H Brennaman, Marcia L Moss, Patricia F Maness
Current Pharmaceutical Biotechnology
|
February 22, 2008
ADAM10 as a target for anti-cancer therapy
Marcia L Moss, Alexander Stoeck, Wenbo Yan, et al.
Clinical Biochemistry
|
October 18, 2011
Potential of fluorescent metalloproteinase substrates for cancer detection
Roopali Roy, David Zurakowski, Susan Pories, et al.
Combinatorial Chemistry & High Throughput Screening
|
December 18, 2009
Fluorescent substrates useful as high-throughput screening tools for ADAM9
Marcia L Moss, Fred H Rasmussen, Raphael Nudelman, et al.
Analytical Biochemistry
|
September 18, 2016
Fluorescent substrates for ADAM15 useful for assaying and high throughput screening
Marcia L Moss, Miles A Miller, Nikola Vujanovic, et al.
Page
of 4